Fabbio Patrick 4
4 · Protara Therapeutics, Inc. · Filed Jan 23, 2024
Insider Transaction Report
Form 4
Fabbio Patrick
Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-19+22,000→ 22,000 total - Award
Stock Option (Right to Buy)
2024-01-19+131,000→ 131,000 totalExercise: $1.91Exp: 2034-01-18→ Common Stock (131,000 underlying)
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024.
- [F2]25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.